Murine CD160, Ig-like receptor on NK Cells and NKT cells, recognizes classical and nonclassical MHC class I and regulates NK cell activation

Journal of Immunology

Volumn 175, Issue 7, 2005, Pages 4426-4432

  Maeda, Motoi ^a,d   Carpenito, Carmine ^a,e   Russell, Ryan C ^a,f   Dasanjh, Jyoti ^a   Veinotte, Linnea L ^a   Ohta, Hideaki ^a,g   Yamamura, Takashi ^b   Tan, Rusung ^c   Takei, Fumio ^a,c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD160 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN RECEPTOR; IONOMYCIN; LECTIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHORBOL ESTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL LINE; CONTROLLED STUDY; CROSS LINKING; DENDRITIC CELL; GENE OVEREXPRESSION; INTERFERON PRODUCTION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 25444496156     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.7.4426     Document Type: Article

References (43)

1. Parham, P. 2005. MHC class I molecules and kirs in human history, health and survival. Nat. Rev. Immunol. 5: 201-214.
2. Takei, F., K. L. McQueen, M. Maeda, B. T. Wilhelm, S. Lohwasser, R. H. Lian, and D. L. Mager. 2001. Ly49 and CD94/NKG2: developmentally regulated expression and evolution. Immunol. Rev. 181: 90-103.
3. 3 interaction inhibits antigen-induced mast cell activation. Nat. Immunol. 2: 436-442.
4. Brown, M. H., K. Boles, P. A. van der Merwe, V. Kumar, P. A. Mathew, and A. N. Barclay. 1998. 2B4, the natural killer and T cell immunoglobulin super-family surface protein, is a ligand for CD48. J. Exp. Med. 188: 2083-2090.
5. -/- mice. Nat. Immunol. 5: 623-629.
6. Hoelsbrekken, S. E., O. Nylenna, P. C. Saether, I. O. Slettedal, J. C. Ryan, S. Possum, and E. Dissen. 2003. Cutting edge: molecular cloning of a killer cell Ig-like receptor in the mouse and rat. J. Immunol. 170: 2259-2263.
7. Welch, A. Y., M. Kasahara, and L. M. Spain. 2003. Identification of the mouse killer immunoglobulin-like receptor-like (Kid) gene family mapping to chromosome X. Immunogenetics 54: 782-790.
8. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237.
9. 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells. J. Immunol. 172: 6115-6122.
10. Maeda, M., S. Lohwasser, T. Yamamura, and F. Takei. 2001. Regulation of NKT cells by Ly49: analysis of primary NKT cells and generation of NKT cell line. J. Immunol. 167: 4180-4186.
11. Chang, C. S., L. Brossay, M. Kronenberg, and K. P. Kane. 1999. The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytolysis. J. Exp. Med. 189: 483-491.
12. Huang, M. M., P. Borszcz, S. Sidobre, M. Kronenberg, and K. P. Kane. 2004. CD1d1 displayed on cell size beads identifies and enriches an NK cell population negatively regulated by CD1d1. J. Immunol. 172: 5304-5312.
13. Campos-Martin, Y., d. M. Gomez, B. Gozalbo-Lopez, J. Suela, and E. Martinez-Naves. 2004. Expression of human CD1d molecules protects target cells from NK cell-mediated cytolysis. J. Immunol. 172: 7297-7305.
14. Maiza, H., G. Leca, I. G. Mansur, V. Schiavon, L. Boumsell, and A. Bensussan. 1993. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity. J. Exp. Med. 178: 1121-1126.
15. Anumanthan, A., A. Bensussan, L. Boumsell, A. D. Christ, R. S. Blumberg, S. D. Voss, A. T. Patel, M. J. Robertson, L. M. Nadler, and G. J. Freeman. 1998. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J. Immunol. 161: 2780-2790.
16. Agrawal, S., J. Marquet, G. J. Freeman, A. Tawab, P. L. Bouteiller, P. Roth, W. Bolton, G. Ogg, L. Boumsell, and A. Bensussan. 1999. Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J. Immunol. 162: 1223-1226.
17. Nikolova, M., A. Marie-Cardine, L. Boumsell, and A. Bensussan. 2002. BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression. Int. Immunol. 14:445-451.
18. Le Bouteiller, P., A. Barakonyi, J. Giustiniani, F. Lenfant, A. Marie-Cardine, M. Aguene-Gin, M. Rabot, I. Hilgert, F. Mami-Chouaib, J. Tabiasco, et al. 2002. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc. Natl. Acad. Sci. USA 99: 16963-16968.
19. Barakonyi, A., M. Rabot, A. Marie-Cardine, M. Aguene-Gin, B. Polgar, V. Schiavon, A. Bensussan, and P. Le Bouteiller. 2004. Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset. J. Immunol. 173: 5349-5354.
20. Fawcett, J., C. L. Holness, L. A. Needham, H. Turley, K. C. Gatter, D. Y. Mason, and D. L. Simmons. 1992. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature 360: 481-484.
21. Lian, R. H., Y. Li, S. Kubota, D. L. Mager, and F. Takei. 1999. Recognition of class I MHC by NK receptor Ly-49C: identification of critical residues. J. Immunol. 162: 7271-7276.
22. Karlhofer, F. M., M. M. Orihuela, and W. M. Yokoyama. 1995. Ly-49-independent natural killer (NK) cell specificity revealed by NK cell clones derived from p53-deficient mice. J. Exp. Med. 181: 1785-1795.
23. Maeda, M., N. Uchida, C. J. Eaves, and F. Takei. 2003. Slow receptor acquisition by NK cells regenerated in vivo from transplanted fetal liver or adult bone marrow stem cells. Exp. Hematol. 31: 1015-1018.
24. Pal, E., T. Tabira, T. Kawano, M. Taniguchi, S. Miyake, and T. Yamamura. 2001. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Va14 NK T cells. J. Immunol. 166: 662-668.
25. Chung, B., A. Aoukaty, J. Dutz, C. Terhorst, and R. Tan. 2005. Cutting edge: signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J. Immunol. 174: 3153-3157.
26. Lian, R. H., J. D. Freeman, D. L. Mager, and F. Takei. 1998. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor. J. Immunol. 161: 2301-2306.
27. Karasuyama, H., A. Kudo, and F. Melchers. 1990. The proteins encoded by the VpreB and λ5 pre-B cell-specific genes can associate with each other and with μ heavy chain. J. Exp. Med. 172: 969-972.
28. Teitell, M., H. R. Holcombe, L. Brossay, A. Hagenbaugh, M. J. Jackson, L. Pond, S. P. Balk, C. Terhorst, P. A. Peterson, and M. Kronenberg. 1997. Nonclassical behavior of the mouse CD1 class I-like molecule. J. Immunol. 158: 2143-2149.
29. Antonchuk, J., G. Sauvageau, and R. K. Humphries. 2001. HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation. Exp. Hematol. 29: 1125-1134.
30. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
31. + T cells upon NKR-P1 cross-linking. J. Exp. Med. 183: 2391-2396.
32. Hoglund, P., J. Sundback, M. Y. Olsson-Alheim, M. Johansson, M. Salcedo, C. Ohlen, H. G. Ljunggren, C. L. Sentman, and K. Karre. 1997. Host MHC class I gene control of NK-cell specificity in the mouse. Immunol. Rev. 155: 11-28.
33. Yang, Y., A. Ueno, M. Bao, Z. Wang, J. S. Im, S. Porcelli, and J. W. Yoon. 2003. Control of NKT cell differentiation by tissue-specific microenvironments. J. Immunol. 171:5913-5920.
34. Horejsi, V., W. Zhang, and B. Schraven. 2004. Transmembrane adaptor proteins: organizers of immunoreceptor signalling. Nat. Rev. Immunol. 4: 603-616.
35. + T cells. J. Exp. Med. 186: 1957-1963.
36. Holowka, D., and B. Baird. 2001. FcεR1 as a paradigm for a lipid raft-dependent receptor in hematopoietic cells. Semin. Immunol. 13: 99-105.
37. Davidson, D., M. Bakinowski, M. L. Thomas, V. Horejsi, and A. Veillette. 2003. Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor. Mol. Cell Biol. 23: 2017-2028.
38. Fawcett, V. C., and U. Lorenz. 2005. Localization of Src homology 2 domain-containing phosphatase 1 (SHP-I) to lipid rafts in T lymphocytes: functional implications and a role for the SHP-1 carboxyl terminus. J. Immunol. 174: 2849-2859.
39. Hanke, T., H. Takjzawa, C. W. McMahon, D. H. Busch, E. G. Pamer, J. D. Miller, J. D. Altman, Y. Liu, D. Cado, F. A. Lemonnier, et al. 1999. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11: 67-77.
40. Michaelsson, J., A. Achour, M. Salcedo, A. Kase-Sjostrom, J. Sundback, R. A. Harris, and K. Karre. 2000. Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur. J. Immunol. 30: 300-307.
41. b-binding receptors in the specificity of developing NK cells. Eur. J. Immunol. 30: 1094-1101.
42. Meyerson, H. J., J. H. Huang, J. D. Fayen, H. M. Tsao, R. R. Getty, N. S. Greenspan, and M. L. Tykocinski. 1996. Functional dissociation of CD8α's Ig homologue and connecting peptide domains. J. Immunol. 156: 574-584.
43. Daniels, M. A., L. Devine, J. D. Miller, J. M. Moser, A. E. Lukacher, J. D. Altman, P. Kavathas, K. A. Hogquist, and S. C. Jameson. 2001. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 15: 1051-1061.